top of page

Pfizer Asks U.S. To Allow Its COVID Shots For Kids Aged 5 To 11

  • Writer: By The Financial District
    By The Financial District
  • Oct 8, 2021
  • 2 min read

Pfizer has asked the US government Thursday to allow the use of its COVID-19 vaccine in children ages 5 to 11 -- and if regulators agree, shots could begin within a matter of weeks, Lauran Neergaard reported for the Associated Press (AP).

Photo Insert: In March 2021, the company announced the first participants had been dosed in a global study evaluating the Pfizer-BioNTech COVID-19 vaccine’s safety, tolerability, and immunogenicity in healthy children between 6 months and 11 years old.

Many parents and pediatricians are clamoring for protection for children younger than 12, today’s age cutoff for the vaccine made by Pfizer and its German partner BioNTech. Not only can youngsters sometimes get seriously ill but keeping them in school can be a challenge with the coronavirus still raging in poorly vaccinated communities. Pfizer announced in a tweet that it had formally filed its application with the Food and Drug Administration (FDA).


Now the FDA will have to decide if there’s enough evidence that the shots are safe and will work for younger children as they do for teens and adults. An independent expert panel will publicly debate the evidence on Oct. 26.


One big change: Pfizer says its research shows the younger kids should get a third of the dose now given to everyone else. After their second dose, the 5- to 11-year-olds developed virus-fighting antibody levels just as strong as teens and young adults get from regular-strength shots.


All the news: Business man in suit and tie smiling and reading a newspaper near the financial district.

While kids are at lower risk of severe illness or death than older people, COVID-19 does sometimes kill children, and cases in youngsters have skyrocketed as the extra-contagious delta variant has swept through the country.


“It makes me very happy that I am helping other kids get the vaccine,” said Sebastian Prybol, 8, of Raleigh, North Carolina. He is enrolled in Pfizer’s study at Duke University and doesn’t yet know if he received the vaccine or dummy shots.


Health & lifestyle: Woman running and exercising over a bridge near the financial district.

“We do want to make sure that it is absolutely safe for them,” said Sebastian’s mother, Britni Prybol. But she said she will be “overjoyed” if the FDA clears the vaccine.





Optimize asset flow management and real-time inventory visibility with RFID tracking devices and custom cloud solutions.
Sweetmat disinfection mat

TFD (Facebook Profile) (1).png
TFD (Facebook Profile) (3).png

Register for News Alerts

  • LinkedIn
  • Instagram
  • X
  • YouTube

Thank you for Subscribing

The Financial District®  2023

bottom of page